PRIYA RAJENDRAN

Dr. PRIYA RAJENDRAN

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2022 in Tuberculosis
Verified
Journal Article
Closed access
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN
MKMichel Prem Kumar
Michel Prem Kumar
KTKannan Thiruvengadam
Kannan Thiruvengadam
PSPrabu Sreenivasan
Prabu Sreenivasan
TVThiyagarajan Veeraraghavan
Thiyagarajan Veeraraghavan
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini

12 August 2025 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
GSGowsalya Saminathan
Gowsalya Saminathan
VKVinod Kumar
Vinod Kumar
SSSivakumar Shanmugam
Sivakumar Shanmugam
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN

17 October 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini
NNNaveenkumar Nagarajan
Naveenkumar Nagarajan
RVRoja Samyuktha V
Roja Samyuktha V
VGVadivu Govindaraju
Vadivu Govindaraju
SSSivakumar Shanmugam
Sivakumar Shanmugam
M. kansasii is the most common non-tuberculous mycobacteria, known to be causing pulmonary and extrapulmonary diseases in humans. Based on molecular methods, M. kansasii has been previously classified into seven different subtypes. Now, based on whole-genome sequence analysis, a new species designation was proposed, in which M. kansasii species was designated subtype 1 and is of pathogenic significance in both immunocompetent and immunocompromised patients. The aim of the study is to examine the distribution of subtypes, based on whole-genome sequence analysis, and identify the genetic determinants of drug resistance for the isolates. Whole-genome sequencing was performed using 12 isolates for which phenotypic DST results were available. A phylogenetic tree was constructed by alignment of each of the 12 isolates and the additional strains, as well as the M. kansasii reference strain, using the MAFFT algorithm. Based on this analysis, all 12 isolates were classified as subtype I. Drug-resistant mutations were identified by analysing the isolates with known drug-resistant loci of MTB and NTM. Although we had mutations in the drug-resistant genes, the significance of those mutations could not be explored due to the minimal availability of data available to compare. Further large-scale studies targeting the phenotypic and genotypic drug-resistance pattern, along with whole-genome analysis, will facilitate a better understanding of the resistance mechanisms involved in M. kansasii.

10 April 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN
STSilla Varghese Thomas
Silla Varghese Thomas
SBSarath Balaji
Sarath Balaji
ESElilarasi Selladurai
Elilarasi Selladurai
GJGanesh Jayachandran
Ganesh Jayachandran
SHSyed Hissar
Syed Hissar
Background: It has been reported that differential diagnosis of bacterial or viral pneumonia and tuberculosis (TB) in infants and young children is complex. This could be due to the difficulty in microbiological confirmation in this age group. In this study, we aimed to assess the utility of a real-time multiplex PCR for diagnosis of respiratory pathogens in children with pulmonary TB.Methods: A total of 185 respiratory samples [bronchoalveolar lavage (15), gastric aspirates (98), induced sputum (21), and sputum (51)] from children aged 3–12 years, attending tertiary care hospitals, Chennai, India, were included in the study. The samples were processed by N acetyl L cysteine (NALC) NAOH treatment and subjected to microbiological investigations for Mycobacterium tuberculosis (MTB) diagnosis that involved smear microscopy, Xpert® MTB/RIF testing, and liquid culture. In addition, DNA extraction from the processed sputum was carried out and was subjected to a multiplex real-time PCR comprising a panel of bacterial and fungal pathogens.Results: Out of the 185 samples tested, a total of 20 samples were positive for MTB by either one or more identification methods (smear, culture, and GeneXpert). Out of these 20 MTB-positive samples, 15 were positive for one or more bacterial or fungal pathogens, with different cycle threshold values. Among patients with negative MTB test results (n = 165), 145 (87%) tested positive for one or more than one bacterial or fungal pathogens.Conclusion: The results suggest that tuberculosis could coexist with other respiratory pathogens causing pneumonia. However, a large-scale prospective study from different geographical settings that uses such simultaneous detection methods for diagnosis of childhood tuberculosis and pneumonia will help in assessing the utility of these tests in rapid diagnosis of respiratory infections.

11 August 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
STSilla Varghese Thomas
Silla Varghese Thomas
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN
SSSivakumar Shanmugam
Sivakumar Shanmugam
This review provides an insight into pediatric tuberculosis (TB) diagnosis in India. Significant challenges still exist in the accurate diagnosis of pediatric TB due to the paucibacillary status of the bacilli and the nonspecific clinical symptoms. Despite advancements in newer diagnostics that allow for rapid identification of TB and detection of drug resistance in children, their sensitivity is compromised due to these challenges. It is crucial to consider that children may not always expectorate sputum, further complicating the diagnostic process. Testing multiple samples, like aspirates, bronchoalveolar lavages, stool, urine, saliva, and swabs, may improve sensitivity. However, the efficacy of using these samples for pediatric TB diagnosis requires extensive research to validate their accuracy and reliability. This is crucial, especially in countries like India, which bears a high burden of TB cases, making the need for novel diagnostic approaches even more pressing. This need for innovative diagnostic approaches is particularly important in countries like India, which bears a high burden of TB cases. Collaborative efforts between researchers, healthcare providers, and policymakers are essential to drive innovation and progress toward achieving the END-TB goal. In this review, we have included studies and case reports published over a decade by utilizing scientific databases like PubMed, Scopus, and Google Scholar, and a set of key search terms including “pediatric TB in India”, and “pediatric TB diagnosis”.

30 April 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
JRJeevarahini Regupathy
Jeevarahini Regupathy
PRPRIYA RAJENDRAN
PRIYA RAJENDRAN
VVVinod Kumar Viswanathan
Vinod Kumar Viswanathan
SSSivakumar Shanmugam
Sivakumar Shanmugam
Tuberculosis (TB) poses serious challenges to healthcare personnel as it continues to be highly prevalent in a developing country like India. Several prominent strategies have been adopted to control this contagious infection, but the incidence rate remains high. Many studies have linked fungal infections to TB, apparently elevating concerns in the TB elimination program. Hence, it is essential to understand the mechanisms underlying TB co-infection and pulmonary mycoses to combat the problems caused by these diseases successfully. In addition, differential diagnosis of TB and fungal infections is equally essential to initiate appropriate treatment. This review attempts to describe misdiagnosis of TB and fungal disease and their relative coexistence in the context of the Indian perspective.